← Open Payments lookup

JAMIE FAUST: Open Payments

NPI 1710521422 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,058 in 34 payments from 14 companies in 2025. Trend: 2023 $145 · 2024 $462 · 2025 $1,058

Food & beverage: $1,058
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.7$221
Ardelyx, Inc.4$183
KYOWA KIRIN, INC.4$176
Novartis Pharmaceuticals Corporation1$89
SCPHARMACEUTICALS INC.3$60
Lilly USA, LLC3$52
Amgen Inc.2$51
AstraZeneca Pharmaceuticals LP2$46
AKEBIA THERAPEUTICS INC2$41
Renalytix AI, Inc.2$39

Products named: TARPEYO, CRYSVITA, XPHOZAH 30 MG, Vanrafia, IBSRELA, FUROSCIX, KRYSTEXXA, Vafseo.

Industry payments across TX — which companies pay providers there.